Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app boost daily functioning for veterans in opioid recovery?

NCT ID NCT06454903

Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This study is developing and testing a smartphone app called ACT to RECOVER, designed to help veterans receiving medication for opioid use disorder improve their daily functioning and quality of life. The app is based on Acceptance and Commitment Therapy (ACT), a well-supported approach that helps people live according to their values despite challenges. The study will first gather feedback from veterans and providers to refine the app, then test it in a small pilot trial comparing it to a symptom-monitoring app. The goal is to see if the app is acceptable, usable, and shows promise for improving outcomes like quality of life and reducing opioid use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A smartphone app called ACT to RECOVER, based on Acceptance and Commitment Therapy, designed to support daily functioning and quality of life for veterans receiving medication for opioid use disorder.
What this could lead to
If successful, this app could provide a convenient, accessible way to help veterans in opioid treatment improve their daily functioning and quality of life, potentially complementing standard care.
What could go wrong
This is an early-stage pilot with a small number of participants, so results may not be conclusive. The app's effectiveness and acceptability are still being tested, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Oct 2029

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: -For the Phase 3, Stage 1b RCT The investigators will be recruiting Veterans engaged in MOUD who also demonstrate deficits in psychosocial functioning (N = 40, n = 20 per condition). Eligible Veterans in must have: * a current Opioid Use Disorder (OUD) diagnosis * active Medication treatment for OUD (MOUD) prescription for buprenorphine or methadone * have a Veterans Rand 12 (VR-12) Physical Component Scale (PCS) or Mental Component Scale (MCS) that is \<1SD below the normed mean for their respective sex-assigned-at-birth (Selim et al., 2008). Exclusion Criteria: Participants may not: * have untreated major psychiatric disorders (e.g., psychotic disorders) * current (i.e., past-month) suicidal/homicidal ideation with intent (i.e., a positive C-SSRS) * cognitive/medical impairments precluding meaningful participation (via clinician determination based on participant's behavior and/or chart review)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Opioid-related disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Opioid-related disorders Psychosocial functioning Quality of life

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    RECRUITING

    West Haven, Connecticut, 06516-2770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.